Eureka Therapeutics, Inc.

Organization

Emeryville, CA, US

Business Address
5858 HORTON ST STE 362 Emeryville CA 94608 (510) 654-7045
Mailing Address
5858 HORTON ST STE 362 Emeryville CA 94608
State Location
CA
State of Incorporation
CA

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antibodies to mucin-16 (MUC16), encoding polynucleotides and method...
- Patent number 12,168,696
- Issue date Dec 17, 2024
- Memorial Sloan Kettering Cancer Center
- David Spriggs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...
- Patent number 12,139,538
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Constructs targeting prostate-specific membrane antigen (PSMA) and...
- Patent number 11,993,661
- Issue date May 28, 2024
- Eureka Therapeutics, Inc.
- Hong Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody agents specific for human CD19 and uses thereof
- Patent number 11,981,742
- Issue date May 14, 2024
- Eureka Therapeutics, Inc.
- Hong Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody/T-cell receptor chimeric constructs and uses thereof
- Patent number 11,976,105
- Issue date May 7, 2024
- Eureka Therapeutics, Inc.
- Jingwei Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cells expressing chimeric activating receptors and chimeric stimula...
- Patent number 11,965,021
- Issue date Apr 23, 2024
- Eureka Therapeutics, Inc.
- Hong Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors targetin...
- Patent number 11,866,478
- Issue date Jan 9, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constructs trageting CD22 and uses thereof
- Patent number 11,827,672
- Issue date Nov 28, 2023
- Eureka Therapeutics, Inc.
- Jun Cui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors targeting G-protein coupled receptor and...
- Patent number 11,820,806
- Issue date Nov 21, 2023
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies targeting B-cell maturation antigen and methods of use
- Patent number 11,725,059
- Issue date Aug 15, 2023
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ROR2 antibodies
- Patent number 11,673,957
- Issue date Jun 13, 2023
- Eureka Therapeutics, Inc.
- Cheng Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antibody/T-cell receptor constructs and uses thereof
- Patent number 11,613,573
- Issue date Mar 28, 2023
- Eureka Therapeutics, Inc.
- Lucas Horan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding anti-GPRC5D antibodies
- Patent number 11,566,071
- Issue date Jan 31, 2023
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T cell receptor-like antibodies specific for Foxp3-derived peptides
- Patent number 11,505,599
- Issue date Nov 22, 2022
- Memorial Sloan Kettering Cancer Center
- David A. Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Constructs specifically recognizing glypican 3 and uses thereof
- Patent number 11,447,564
- Issue date Sep 20, 2022
- Eureka Therapeutics, Inc.
- Pengbo Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody/T-cell receptor chimeric constructs and uses thereof
- Patent number 11,421,013
- Issue date Aug 23, 2022
- Eureka Therapeutics, Inc.
- Jingwei Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cell receptor-like antibodies specific for a PRAME peptide
- Patent number 11,384,144
- Issue date Jul 12, 2022
- Memorial Sloan Kettering Cancer Center
- David A. Scheinberg
- G01 - MEASURING TESTING
Information Patent Grant
Constructs targeting histone H3 peptide/MHC complexes and uses thereof
- Patent number 11,274,157
- Issue date Mar 15, 2022
- Eureka Therapeutics, Inc.
- Vivien Wai-Fan Chan
- G01 - MEASURING TESTING
Information Patent Grant
Monoclonal antigen-binding proteins to intracellular oncogene products
- Patent number 11,242,405
- Issue date Feb 8, 2022
- Memorial Sloan Kettering Cancer Center
- David A. Scheinberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T cell receptor-like antibody agents specific for EBV latent membra...
- Patent number 11,168,150
- Issue date Nov 9, 2021
- Memorial Sloan Kettering Cancer Center
- Nai-Kong V. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ROR1 antibodies
- Patent number 11,155,615
- Issue date Oct 26, 2021
- Eureka Therapeutics, Inc.
- Brian Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-1 immune modulating agents
- Patent number 11,136,392
- Issue date Oct 5, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-KIR3DL1 antibodies
- Patent number 11,117,964
- Issue date Sep 14, 2021
- Memorial Sloan Kettering Cancer Center
- Katharine Hsu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-1 immune modulating agents
- Patent number 11,104,733
- Issue date Aug 31, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...
- Patent number 11,059,891
- Issue date Jul 13, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using chimeric antigen receptors targeting B-cell matura...
- Patent number 11,000,549
- Issue date May 11, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies targeting b-cell maturation antigen and methods of use
- Patent number 10,947,314
- Issue date Mar 16, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting B-cell maturation antigen and...
- Patent number 10,918,665
- Issue date Feb 16, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies targeting Fc receptor-like 5 and methods of use
- Patent number 10,913,796
- Issue date Feb 9, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatments using chimeric antigen receptors targeting G-...
- Patent number 10,906,956
- Issue date Feb 2, 2021
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CONSTRUCTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND...
- Publication number 20250011463
- Publication date Jan 9, 2025
- Eureka Therapeutics, Inc.
- Hong LIU
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...
- Publication number 20240335475
- Publication date Oct 10, 2024
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULA...
- Publication number 20240317855
- Publication date Sep 26, 2024
- Eureka Therapeutics, Inc.
- Hong LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND...
- Publication number 20240294599
- Publication date Sep 5, 2024
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE
- Publication number 20240076370
- Publication date Mar 7, 2024
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS TARGETING NDC80/MHC COMPLEXES AND USES THEREOF
- Publication number 20230374140
- Publication date Nov 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Martin KLATT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
- Publication number 20230293687
- Publication date Sep 21, 2023
- Eureka Therapeutics, Inc.
- Cheng Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF
- Publication number 20230048360
- Publication date Feb 16, 2023
- Eureka Therapeutics, Inc.
- Pengbo ZHANG
- G01 - MEASURING TESTING
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES TH...
- Publication number 20230020729
- Publication date Jan 19, 2023
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF
- Publication number 20220348629
- Publication date Nov 3, 2022
- Eureka Therapeutics, Inc.
- Jingwei LU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC STIMULATIN...
- Publication number 20220323497
- Publication date Oct 13, 2022
- Eureka Therapeutics, Inc.
- Hongruo YUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE
- Publication number 20220315660
- Publication date Oct 6, 2022
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR T CELLS AND USES THEREOF
- Publication number 20220265715
- Publication date Aug 25, 2022
- Eureka Therapeutics, Inc.
- Hongruo YUN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FOXP3 TARGETING AGENT COMPOSITIONS AND METHODS OF USE FOR ADOPTIVE...
- Publication number 20220267420
- Publication date Aug 25, 2022
- Memorial Sloan-Kettering Cancer Center
- David A. SCHEINBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF
- Publication number 20220235143
- Publication date Jul 28, 2022
- Memorial Sloan-Kettering Cancer Center
- David SPRIGGS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONSTRUCTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND...
- Publication number 20220185910
- Publication date Jun 16, 2022
- Eureka Therapeutics, Inc.
- Hong LIU
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL I...
- Publication number 20220119501
- Publication date Apr 21, 2022
- Eureka Therapeutics, Inc.
- Cheng LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF
- Publication number 20210403597
- Publication date Dec 30, 2021
- Memorial Sloan-Kettering Cancer Center
- David SPRIGGS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING FC RECEPTOR-LIKE 5 AND METHODS OF USE
- Publication number 20210388081
- Publication date Dec 16, 2021
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...
- Publication number 20210346432
- Publication date Nov 11, 2021
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIGEN-BINDING PROTEINS TO INTRACELLULAR ONCOGENE PRODUCTS
- Publication number 20210332150
- Publication date Oct 28, 2021
- Memorial Sloan-Kettering Cancer Center
- David A. SCHEINBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF
- Publication number 20210277117
- Publication date Sep 9, 2021
- Eureka Therapeutics, Inc.
- Cheng LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF
- Publication number 20210253665
- Publication date Aug 19, 2021
- Eureka Therapeutics, Inc.
- Jingwei LU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR A WTI PEPTIDE PRESENTE...
- Publication number 20210163624
- Publication date Jun 3, 2021
- Memorial Sloan-Kettering Cancer Center
- David Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULA...
- Publication number 20210107976
- Publication date Apr 15, 2021
- Eureka Therapeutics, Inc.
- Hong LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF
- Publication number 20210107992
- Publication date Apr 15, 2021
- Eureka Therapeutics, Inc.
- Pengbo ZHANG
- G01 - MEASURING TESTING
Information Patent Application
CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND SECONDARY EFFECTORS...
- Publication number 20210093666
- Publication date Apr 1, 2021
- Eureka Therapeutics, Inc.
- Binnaz K. STALEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRUCTS TRAGETING CD22 AND USES THEREOF
- Publication number 20210017280
- Publication date Jan 21, 2021
- Eureka Therapeutics, Inc.
- Jun CUI
- G01 - MEASURING TESTING
Information Patent Application
NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS TARGETIN...
- Publication number 20200276240
- Publication date Sep 3, 2020
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...
- Publication number 20200276239
- Publication date Sep 3, 2020
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90328357 - INVISIMASK
- Serial number 90328357
- Filing date Nov 18, 2020
- Eureka Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87840660 - ET
- Serial number 87840660
- Registration number 5758909
- Filing date Mar 19, 2018
- Eureka Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87182079 - E-ALPHA
- Serial number 87182079
- Registration number 5298051
- Filing date Sep 23, 2016
- Eureka Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86973407
- Serial number 86973407
- Registration number 5032043
- Filing date Apr 12, 2016
- Eureka Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86973388 - EUREKA THERAPEUTICS
- Serial number 86973388
- Registration number 5816334
- Filing date Apr 12, 2016
- Eureka Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86880860 - ARTEMIS
- Serial number 86880860
- Registration number 5897433
- Filing date Jan 20, 2016
- Eureka Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations

Eureka Therapeutics, Inc.

Organization

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Antibodies to mucin-16 (MUC16), encoding polynucleotides and method...

Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...

Constructs targeting prostate-specific membrane antigen (PSMA) and...

Antibody agents specific for human CD19 and uses thereof

Antibody/T-cell receptor chimeric constructs and uses thereof

Cells expressing chimeric activating receptors and chimeric stimula...

Nucleic acid molecules encoding chimeric antigen receptors targetin...

Constructs trageting CD22 and uses thereof

Chimeric antigen receptors targeting G-protein coupled receptor and...

Antibodies targeting B-cell maturation antigen and methods of use

Anti-ROR2 antibodies

Chimeric antibody/T-cell receptor constructs and uses thereof

Nucleic acid molecules encoding anti-GPRC5D antibodies

T cell receptor-like antibodies specific for Foxp3-derived peptides

Constructs specifically recognizing glypican 3 and uses thereof

Antibody/T-cell receptor chimeric constructs and uses thereof

T cell receptor-like antibodies specific for a PRAME peptide

Constructs targeting histone H3 peptide/MHC complexes and uses thereof

Monoclonal antigen-binding proteins to intracellular oncogene products

T cell receptor-like antibody agents specific for EBV latent membra...

Anti-ROR1 antibodies

PD-1 immune modulating agents

Anti-KIR3DL1 antibodies

PD-1 immune modulating agents

Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...

Methods of using chimeric antigen receptors targeting B-cell matura...

Antibodies targeting b-cell maturation antigen and methods of use

Chimeric antigen receptors targeting B-cell maturation antigen and...

Antibodies targeting Fc receptor-like 5 and methods of use

Methods of treatments using chimeric antigen receptors targeting G-...

Patents Applicationslast 30 patents

CONSTRUCTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND...

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...

CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULA...

CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND...

ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE

COMPOSITIONS TARGETING NDC80/MHC COMPLEXES AND USES THEREOF

T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF

CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES TH...

ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF

CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC STIMULATIN...

ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE

CHIMERIC ANTIGEN RECEPTOR T CELLS AND USES THEREOF

FOXP3 TARGETING AGENT COMPOSITIONS AND METHODS OF USE FOR ADOPTIVE...

HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

CONSTRUCTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND...

COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL I...

ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

ANTIBODIES TARGETING FC RECEPTOR-LIKE 5 AND METHODS OF USE

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...

MONOCLONAL ANTIGEN-BINDING PROTEINS TO INTRACELLULAR ONCOGENE PRODUCTS

CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF

T CELL RECEPTOR-LIKE ANTIBODIES SPECIFIC FOR A WTI PEPTIDE PRESENTE...

CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULA...

CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF

CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND SECONDARY EFFECTORS...

CONSTRUCTS TRAGETING CD22 AND USES THEREOF

NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS TARGETIN...

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...

Trademarklast 30 trademarks

90328357 - INVISIMASK

87840660 - ET

87182079 - E-ALPHA

86973407

86973388 - EUREKA THERAPEUTICS

86880860 - ARTEMIS